By: Sundar Ganesan, Katsiaryna Uss, Farzana Bhuyan, Vinod Nair, Amitava Roy, Philip J. Kahn, Sachin Gaurav, Deborah Consolini, Juraj Kabat, Nathan T. Brandes, Ronit Herzog, Clinton Bradfield, Douglas Kuhns, Sara Alehashemi, Raphaela Goldbach-Mansky
Abstract De novo mutations underlying early-onset systemic autoinflammatory diseases have identified key regulators of innate immunity, including pathways that drive IL-1-mmediated inflammation.












